-
Pfizer, BioNTech to Provide 500M COVID Vax Doses to U.S. for Donation
contractpharma
June 11, 2021
Pfizer Inc. and BioNTech SE plan to provide the U.S. government at a not-for-profit price 500 million doses of the companies’ COVID-19 vaccine, 200 million doses in 2021 and 300 million doses in 1H22.
-
Valneva completes Phase 3 trial recruitment for its inactivated COVID-19 vaccine candidate
worldpharmanews
June 10, 2021
Valneva SE announced that it has completed recruitment for the pivotal Phase 3 trial of its inactivated, adjuvanted COVID-19 vaccine candidate, VLA2001.
-
EMA to assess whether COVID-19 Vaccine Moderna can be used in adolescents
europeanpharmaceuticalreview
June 10, 2021
The European Medicines Agency (EMA) has begun evaluating whether to extend the use of the COVID-19 Vaccine Moderna to include adolescents aged 12 to 17.
-
Bharat Biotech facility in Hyderabad gets CISF cover
expresspharma
June 10, 2021
The Centre has accorded a security cover of armed CISF commandos for the Hyderabad premises of Bharat Biotech, one of the major COVID-19 vaccine manufacturers in the country, official sources said on Tuesday.
-
Moderna and Medison Pharma Partner to Commercialize Moderna's COVID-19 Vaccine Across Central Eastern Europe and Israel
americanpharmaceuticalreview
June 09, 2021
Moderna Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines and Medison Pharma, a leading commercial partner for highly innovative therapies in international markets, announced a new agreement to commercialize the ...
-
MHRA authorises Pfizer/BioNTech’s COVID-19 vaccine for 12- to 15-year-olds
pharmatimes
June 08, 2021
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has extended the authorisation of Pfizer/BioNTech’s COVID-19 vaccine for use in children aged 12 to 15 years old.
-
Covid-19 vaccines show efficacy in adolescents, paving path towards herd immunity
pharmaceutical-technology
June 08, 2021
There are globally now more people vaccinated for COVID-19 than confirmed cases of COVID-19. With globally over 400 million people fully vaccinated and over 1.7 billion vaccine doses administered, herd immunity seems achievable.
-
Exelead Helps Manufacture Pfizer-BioNTech COVID-19 Vaccine
contractpharma
June 08, 2021
Pharmaceutical development and manufacturing company delivers first vaccine batch to Pfizer.
-
AGC Biologics Inks Supply Deal for COVID-19 Vaccine
contractpharma
June 08, 2021
CDMO’s Heidelberg facility to supply plasmid DNA for Pfizer/BioNTech COVID-19 vaccine.
-
Pfizer Covid-19 vaccine approved for adolescents in the UK
pharmaceutical-technology
June 07, 2021
The approval of Pfizer and BioNTech’s Covid-19 vaccine COMIRNATY in the UK has been expanded to include individuals between 12 and 15 years of age.